Primary Site >> Pancreatic Cancer
Gene >> ABCC2
| 1. | |||||||||||
| Journal: | Lab Invest. 2002 Feb;82(2):193-201. | ||||||||||
| Title: | Tissue distribution and induction of human multidrug resistant protein 3. | ||||||||||
| Author: | Scheffer, George L|Kool, Marcel|de Haas, Marcel|de Vree, J Marleen L|Pijnenborg, Adriana C L M|Bosman, Diederik K|Elferink, Ronald P J Oude|van der Valk, Paul|Borst, Piet|Scheper, Rik J | ||||||||||
| PMID: | 11850532 | ||||||||||
| 2. | |||||||||||
| Journal: | HPB (Oxford). 2007;9(2):150-5. | ||||||||||
| Title: | Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients. | ||||||||||
| Author: | Bai, Jianfeng|Sata, Naohiro|Nagai, Hideo | ||||||||||
| PMID: | 18333132 | ||||||||||
| 3. | |||||||||||
| Journal: | Int J Oncol. 2008 Dec;33(6):1187-94. | ||||||||||
| Title: | Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer. | ||||||||||
| Author: | Noma, Bunjiro|Sasaki, Tamito|Fujimoto, Yoshifumi|Serikawa, Masahiro|Kobayashi, Kenso|Inoue, Motoki|Itsuki, Hiroshi|Kamigaki, Michihiro|Minami, Tomoyuki|Chayama, Kazuaki | ||||||||||
| PMID: | 19020751 | ||||||||||
| 4. | |||||||||||
| Journal: | Pancreatology. 2009;9(1-2):136-44. | ||||||||||
| Title: | ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. | ||||||||||
| Author: | Hagmann, Wolfgang|Jesnowski, Ralf|Faissner, Ralf|Guo, Changqing|Lohr, J Matthias | ||||||||||
| PMID: | 19077464 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer. 2011 Feb 15;117(4):744-51. | ||||||||||
| Title: | Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. | ||||||||||
| Author: | Tanaka, Motofumi|Okazaki, Taro|Suzuki, Hideo|Abbruzzese, James L|Li, Donghui | ||||||||||
| PMID: | 20922799 | ||||||||||
| 6. | |||||||||||
| Journal: | Anat Rec (Hoboken). 2012 Dec;295(12):2122-8. | ||||||||||
| Title: | Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line. | ||||||||||
| Author: | Xiao, Zhi|Ding, Nianhua|Xiao, Guiqing|Wang, Shouman|Wu, Yuhui|Tang, Lili | ||||||||||
| PMID: | 22907845 | ||||||||||
| 7. | |||||||||||
| Journal: | Mol Oncol. 2013 Aug;7(4):840-9. | ||||||||||
| Title: | Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer. | ||||||||||
| Author: | Horiguchi, Shigeru|Shiraha, Hidenori|Nagahara, Teruya|Kataoka, Jyunnro|Iwamuro, Masaya|Matsubara, Minoru|Nishina, Shinichi|Kato, Hironari|Takaki, Akinobu|Nouso, Kazuhiro|Tanaka, Takehiro|Ichimura, Koichi|Yagi, Takahito|Yamamoto, Kazuhide | ||||||||||
| PMID: | 23664167 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncotarget. 2015 May 10;6(13):10853-67. | ||||||||||
| Title: | The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2. | ||||||||||
| Author: | Skrypek, Nicolas|Vasseur, Romain|Vincent, Audrey|Duchene, Belinda|Van Seuningen, Isabelle|Jonckheere, Nicolas | ||||||||||
| PMID: | 25890497 | ||||||||||
| 9. | |||||||||||
| Journal: | Tumour Biol. 2016 Jun;37(6):7555-64. | ||||||||||
| Title: | Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine. | ||||||||||
| Author: | Gao, Chong-Chong|Xu, Xiao-Lan|Li, Fei|Gong, Ben-Gang|Liu, Shuang|Cui, Ye-Qing|Sun, Hai-Chen|Xu, Ping-Yong|Zheng, Ya-Min|Jiang, Hua | ||||||||||
| PMID: | 26684804 | ||||||||||
| 10. | |||||||||||
| Journal: | Front Pharmacol. 2017 Mar 27;8:155. | ||||||||||
| Title: | Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine. | ||||||||||
| Author: | Grixti, Justine M|O'Hagan, Steve|Day, Philip J|Kell, Douglas B | ||||||||||
| PMID: | 28396636 | ||||||||||